QuitinMyJob
4 years ago
ORVRF -- Dollars coming soon
https://www.otcmarkets.com/stock/ORVRF/news/story?e&id=1765336
Orchid Ventures Subsidiary Purtec Announces the Launch of a Significant Advancement in Vaporizer Technology
VANCOUVER, WA / ACCESSWIRE / December 14, 2020 / ORCHID VENTURES, INC. (CSE:ORCD)(OTC PINK:ORVRF) (the "Company" or "Orchid"), a multi-state cannabis innovation company, announces that its wholly owned subsidiary, PurTec Delivery Systems has launched an innovative, proprietary, patent-pending ceramic film atomization heating technology and the first cotton-free vaporizer technology, PurCore F1, in joint development with their strategic partner, JWEI Group Advanced Technology Research Institute, built on the JWEI µKera Ultra technology platform. The Company believes this new technology will transform and disrupt the status quo throughout the cannabis vaporizer industry by providing consumers with higher-performing products that deliver a more optimal user experience with benefits that include a smoother draw, more flavor and less harshness, all while dramatically improving consumer safety.
https://www.accesswire.com/users/newswire/images/620752/0bc797d6-5d6c-4a55-b22d-2c36ed7a31f5.png
PurCore F1 is the world's first Cotton-Free and balanced heating atomization technology. PurTec establishes that the heating element of PurCore F1 and the oil-conducting material have achieved nano-level fusion, effecting the 2-D heating of the entire liquid-conducting surface. Nano-level fusion means that PurCore F1 has made substantial breakthroughs in terms of service life, heating efficiency, atomization efficiency and carbon deposition, so that its comprehensive stability in high viscosity oil applications has increased by approximately 80%. PurCore F1 and the JWEI µKera Ultra Technology Platform is a breakthrough in the industry that not only lengthens the lifespan and improves the heating and vaporization efficiency with its three times larger heating area compared to ceramic cell products, but also drastically reduces the carbonyl emissions that are found in other ceramic and cotton coil vaping products.
Vaporizer performance is the key to consumer satisfaction while ensuring material safety is fundamental. The PurCore F1 consists of a food grade silicate ceramic wick and precious metal heating element. The F1 porous ceramic wick has been compiled with many regulations such as RoHS 2.0, REACH, European and FDA Food Grade Materials and others. The heating element material is well known for its biocompatibility and has been extensively used in medical applications. In addition, PurCore F1 strives for excellence in raw material selection. The heating materials are selected from precious metal biomaterials that are widely used in medical devices and in terms of fluid conduction, food-grade contact materials certified by the FDA.
"The release of PurCore F1 in collaboration with our strategic partner JWEI Group, is a milestone breakthrough in electronic vaporizer technology. This is the first of a series of technological advancements that we have been developing over the last 16 months. The service life of PurCore F1 measured higher than any cartridge we've tested by a substantial margin, resulting in a life of 2,500 puffs, making it possible to have a true cotton-free system. Not only that, the nano-level fusion greatly improves the efficiency of oil heating and atomization. Experiments conducted in the research phase of development showed that PurCore F1 significantly improves consumer safety, specifically regarding carbon deposition and carbonyl emissions of cotton and ceramic atomization cores." Said Corey Mangold, CEO of Orchid Ventures. "The PurTec Innovation Team along with the JWEI Group have created an advancement program that will involve introducing several new technologies over the coming months, all focused on consumer safety and protection, and product performance, starting with PurCore F1, which will become the new gold standard in the industry. The patent pending PurCore F1 technology will launch its first series of products in early 2021, and is currently in preparation and development for upcoming FDA regulations pending the federal legalization of cannabis."
Dr. Bo Jiang, PhD. of the JWEI Group stated, "The birth of PurCore F1 ceramic film heating technology will bring users an entirely new product experience. We continue to set the bar when it comes to vaporizer technology and constantly improving on our pursuit of technological advancements with our design and engineering team in Switzerland, to our manufacturing teams in China, and in joint development with our strategic partner PurTec. We continue to establish ourselves as not only one of the largest manufacturers of vaporizers in the world, but the pioneer of the industry. We are excited for the future as we continue to collaborate and design new innovations with the PurTec Team, in the vaporization of cannabis products that will advance consumer safety, efficacy and ultimately deliver a superior experience to the consumer."
Please forward any questions regarding our new PurCore F1 vaporizer technology or inquiries about product availability to sales@purtecdesigns.com. .
Or, learn more at www.PurTecDesigns.com/PurCoreF1
ABOUT ORCHID VENTURES
Orchid Ventures is an Irvine, CA-based cannabis innovation company, that launched in Oregon and California in August 2017 and has since developed a mass-market brand and loyal consumer following with its premium cannabis products and unique vape hardware delivery system. Since July 2019, Orchid has diversified its efforts and has brought to market innovative services and product offerings to support brands throughout the global cannabis industry. Orchid has diversified its portfolio to include PurTec Delivery Systems, a company that produces, markets and sells clean vaporizer hardware that has been emissions tested against the most stringent standards in the world set forth by the EU and has unrivaled product quality and value pricing. Orchid, through its wholly owned subsidiary, has launched a patented and clinically proven bioavailability solution to increase the absorption of THC and other cannabinoids making products much more effective and an activation time of less than ten minutes. With a continued focus on brand and intellectual property development, Orchid will continue to create new and innovative products and technologies, then bring them to the global cannabis marketplace and set the gold standard for delivery systems whether it's vape or
formulation sciences. Orchid's management brings significant branding, product development and distribution experience with a proven track record of scaling businesses and building sustainable revenue growth through value-generating partnerships and innovation that creates enterprise value. Learn more at https://orchidessentials.com/
ON BEHALF OF THE BOARD OF DIRECTORS - ORCHID VENTURES, INC.
Corey Mangold
CEO and Director
investors@orchidessentials.com
Investor Relations
Corey Mangold
949-357-5818
corey@orchidessentials.com
The CSE does not accept responsibility for the adequacy or accuracy of this release.
Safe Harbor Statement
Except for historical information contained herein, statements in this release may be forward-looking and made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Words such as "anticipate", "believe", "estimate", "expect", "intend" and similar expressions, as they relate to Orchid Ventures, Inc. and Orchid Essentials any of its affiliates or subsidiaries (collectively, the "Company") or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the Company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in the Company's Canadian securities regulatory filings with sedar.com, Factors which could cause actual results to differ materially from these forward-looking statements include such factors as (i) the development and protection of our brands and other intellectual property, (ii) the need to raise capital to meet business requirements, (iii) significant fluctuations in marketing expenses, (iv) the ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of our products and services, (v) the Company's ability to conduct the business if there are changes in laws, regulations, or government policies related to cannabis, (vi) management's ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and (vii) other information that may be detailed from time to time in the Company's Canadian securities regulatory filings with sedar.com. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
SOURCE: Orchid Ventures, Inc.
View source version on accesswire.com:
https://www.accesswire.com/620752/Orchid-Ventures-Subsidiary-Purtec-Announces-the-Launch-of-a-Significant-Advancement-in-Vaporizer-Technology
Buellersback
4 years ago
ORVRF NEWS! Orchid Ventures Announces Upcoming Launch of First THC Products with CellG8(R) Technology and the Appointment of an Independent
Symbols: ORVRF, ORCD
Date: June 2, 2020
Orchid Ventures Announces Upcoming Launch of First THC Products with CellG8(R) Technology and the Appointment of an Independent Director
IRVINE, CA -- June 2, 2020 -- InvestorsHub NewsWire -- ORCHID VENTURES, INC. (ORCD.CN)(OTC PINK:ORVRF) (the "Company" or "Orchid"), a multi-state cannabis innovation company is pleased to announce it is nearing the public launch of the first THC edibles with CELLg8® technology. After over a month of formulation with Stash Brands, LLC a multi-state edibles and concentrates brand, the company has created it's new all-natural, vegan line of 10mg THC gummies that take effect in less than five minutes. The company also announces the appointment of Wayne Johnson, TEP.
"We are very excited to be at the finish line with the first CELLg8® Sciences client and feel that this launch is going to be a big shift in the orally consumed cannabis products market. This first launch with Stash will not only dramatically increase their opportunity to grab market share, it will show to all other edibles, drinks, and topicals manufacturers that CELLg8® won't be an option for their products, it will be required to compete in those sectors. I don't believe that a consumer is going to want to purchase unpredictable products that take up to an hour and a half to kick in, they're going to demand products with CELLg8® that have clinically proven absorption and kick in nearly immediately. Being that CELLg8® is all natural, vegan, contains no surfactants, and has a published clinical safety study and a published clinical absorption study, gives any company the comfort in knowing CELLg8® will not only enhance their product dramatically, but won't compromise the quality of their existing formulation." said Corey Mangold, Founder & CEO. "Furthermore, we're excited to announce the appointment of Wayne Johnson, TEP to our Board of Directors. Wayne has been an advisor to Orchid for nearly three years and is deeply trusted by the Orchid executive team. Wayne's tax and legal genius are a huge value add for our organization and we trust that Wayne will add more value outside of his areas of expertise."
Source for clinical studies: American Journal of Endocannabinoid Medicine
http://cellg8sciences.com/wp-content/uploads/2020/02/Safety-Study-Published-2.pdf
https://cellg8.com/wp-content/uploads/2020/04/Liposomal-Cannabidiol-Delivery-AJCEM.pdf
"Being dispensary operators in multiple states, we know first-hand how consumers use cannabis-infused products in their everyday lives. The application of CELLg8®'s technology to our Stash Brand formulations should provide cutting edge product innovation that consumers are looking for", explained Sean Davis, CEO of Stash Brands, LLC. "Having clinically proven absorption, we're confident this partnership will deliver a point of differentiation on dispensary shelves in every market we bring online".
Wayne R. Johnson, TEP is the founding member of Wayne R. Johnson & Associates, PLC, a boutique law firm located in Beverly Hills, California. Wayne's practice is concentrated in the areas of corporate and general business matters, entertainment and music law and transactions, domestic and international tax planning and controversy, business strategy and planning, and mergers and acquisitions. Wayne earned B.S. degrees in accounting, business finance and economics from North Dakota State University in 1989; a Juris Doctorate (with Distinction) from the University of North Dakota School of Law in 1994; and a Master of Laws degree (LL.M.) in Taxation Law from New York University School of Law in 1995.
Wayne is a member of the State Bar of California, the Society of Trust and Estate Practitioners, and admitted to practice before the U.S. Tax Court, the U.S. District Court for the Central District of California, and the Ninth Circuit Court of Appeals. He has also been an active member of several bar associations, including the State Bar of California, and is a former chair of the California State Bar's Taxation Section (2008-2009).
Law and Politics Magazine and the publishers of Los Angeles Magazine named Wayne a SuperLawyer in the field of taxation law from 2009 to 2020. In November 2011, Wayne received the V. Judson Klein Award from the California State Bar's Taxation Section. The V. Judson Klein Award is annually presented to a mid-career California attorney who displays excellence, professionalism and leadership in the field of taxation law.
ABOUT ORCHID ESSENTIALS
Orchid Essentials is an Irvine, CA-based multi-state operator that launched in Oregon and California in August 2017 and has since developed a mass-market brand and loyal consumer following with its premium cannabis products and unique vape hardware delivery system. Since July 2019, Orchid has diversified its efforts and has brought to market innovative services and product offerings to support brands throughout the global cannabis industry. Orchid has diversified its portfolio to include PurTec Delivery Systems, a company that produces, markets and sells clean vaporizer hardware that has been emissions tested against the most stringent standards in the world set forth by the EU and has unrivaled product quality and value pricing. Orchid, through its wholly-owned subsidiary, has launched a patented and clinically proven bioavailability solution to increase the absorption of THC and other cannabinoids making products much more effective and an activation time of less than five minutes. With a continued focus on brand and intellectual property development, Orchid will continue to create new and innovative products and technologies, then bring them to the global cannabis marketplace and set the gold standard for delivery systems whether it's vape or formulation sciences. Orchid's management brings significant branding, product development and distribution experience with a proven track record of scaling businesses and building sustainable revenue growth through value-generating partnerships and innovation that creates enterprise value. Learn more at https://orchidessentials.com/
ON BEHALF OF THE BOARD OF DIRECTORS - ORCHID VENTURES, INC.
Corey Mangold
CEO and Director
investors@orchidessentials.com
Investor Relations
Corey Mangold
949-357-5818
corey@orchidessentials.com
The CSE does not accept responsibility for the adequacy or accuracy of this release.
Safe Harbor Statement
Except for historical information contained herein, statements in this release may be forward-looking and made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Words such as "anticipate", "believe", "estimate", "expect", "intend" and similar expressions, as they relate to Orchid Ventures, Inc. and Orchid Essentials any of its affiliates or subsidiaries (collectively, the "Company") or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the Company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in the Company's Canadian securities regulatory filings with sedar.com, Factors which could cause actual results to differ materially from these forward-looking statements include such factors as (i) the development and protection of our brands and other intellectual property, (ii) the need to raise capital to meet business requirements, (iii) significant fluctuations in marketing expenses, (iv) the ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of our products and services, (v) the Company's ability to conduct the business if there are changes in laws, regulations, or government policies related to cannabis, (vi) management's ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and (vii) other information that may be detailed from time to time in the Company's Canadian securities regulatory filings with sedar.com. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
SOURCE: Orchid Ventures, Inc.
Golden Cross
5 years ago
News Out - Orchid Ventures Closes Oversubscribed Private Placement
Link:
https://www.accesswire.com/564019/Orchid-Ventures-Closes-Oversubscribed-Private-Placement
Thursday, October 24, 2019 6:30 AM
IRVINE, CA / ACCESSWIRE / October 24, 2019 / Multi-state operator Orchid Ventures, Inc. (CSE:ORCD)(OTC PINK:ORVRF) ("Orchid Ventures" or the "Company") announces that it has closed its previously announced non-brokered private placement (the "Offering") with the issuance of a total of 9,826,756 Units for gross proceeds of $1,179,210. Each Unit consists of one common share and one full-share purchase warrant (a "Warrant") (the "Units"). Each full Warrant entitles the holder to acquire one common share at $0.18 per share for 24 months following closing. The financing was oversubscribed and the net proceeds from the Offering are planned to fund specific initiatives that are intended to accelerate revenue growth within existing Orchid assets and brands, plus complete operational enhancements that are expected to improve profitability. Founder and CEO Corey Mangold stated, "We are very pleased with the level of interest in the Company and our future growth initiatives, as reflected in the oversubscribed placement. The additional funding will directly enable an expanded product development program and allow us to battle for more market share in both Oregon and California."
All securities issued in connection with the Offering will be subject to a statutory hold period of four months plus a day from the date of issuance in accordance with applicable securities legislation.
The securities issued pursuant to the Offering have not been registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), and may not be offered or sold in the United States absent registration or applicable exemption from the registration requirements. This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities issued by the Company pursuant to the Offering are "restricted securities" as defined under Rule 144(a)(3) of the U.S. Securities Act and contain the appropriate restrictive legends as required under the U.S. Securities Act and Canadian Securities Administrators National Instrument 45-102.
ABOUT ORCHID ESSENTIALS
Orchid Essentials is an Irvine, CA-based multi-state operator that launched in Oregon and California in August 2017 and has since developed a mass-market brand and loyal consumer following with its premium cannabis products. Orchid's product lines are currently sold in 350+ dispensaries across California and Oregon and are handcrafted and designed for optimal user-experience and overall enjoyment. The company's proven processes and passion for what it does carry through into its products. The end result is an unparalleled experience for new and practiced cannabis users alike. Orchid plans to expand its operations into new national markets, as well as global markets such as Latin America and Europe. With a continued focus on brand and intellectual property development, Orchid will continue to execute strategic acquisitions to further solidify it's vertically integrated infrastructure with the goal of becoming a dominant premium cannabis company in the United States. Orchid's management brings significant branding, product development and distribution experience with a proven track record of scaling revenues, building value-generating partnerships and creating enterprise value. Learn more at https://orchidessentials.com/
ON BEHALF OF THE BOARD OF DIRECTORS - ORCHID VENTURES, INC.
Corey Mangold
CEO and Director
investors@orchidessentials.com
Investor Relations
Antonio Cruz
(949) 769-3859
a.cruz@orchidventures.com
The CSE does not accept responsibility for the adequacy or accuracy of this release.
Safe Harbor Statement
Except for historical information contained herein, statements in this release may be forward-looking and made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Words such as "anticipate", "believe", "estimate", "expect", "intend" and similar expressions, as they relate to Orchid Ventures, Inc. and Orchid Essentials any of its affiliates or subsidiaries (collectively, the "Company") or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the Company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in the Company's Canadian securities regulatory filings with sedar.com, Factors which could cause actual results to differ materially from these forward-looking statements include such factors as (i) the development and protection of our brands and other intellectual property, (ii) the need to raise capital to meet business requirements, (iii) significant fluctuations in marketing expenses, (iv) the ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of our products and services, (v) the Company's ability to conduct the business if there are changes in laws, regulations, or government policies related to cannabis, (vi) management's ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and (vii) other information that may be detailed from time to time in the Company's Canadian securities regulatory filings with sedar.com. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
SOURCE: Orchid Ventures, Inc.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Ask ADVFN Intelligence (AI)
Renee
4 years ago
Cappello
5 years ago
MADDSTACKER
5 years ago
nowwhat2
5 years ago
Hot Features
Premium
